Investors are still excited about obesity treatments and weight-management drugs.
It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.
Stocks that traded heavily or had substantial price changes on Monday: Boeing, Alaska Air Group fall; Harpoon Therapeutics, Axonics rise
December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...
A triple-witching day means it could be a rough end to a trading week. Before you step away for the holidays, here are some of the top articles from this week.
Harpoon Therapeutics offers an example of biotech's volatility. The stock advanced as much as 191% intraday Monday before settling down to a gain of 22.61%.
This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023
Harpoon Therapeutics, Inc. (NASDAQ: HARP) is engaged as a clinical-stage immune-oncology company, which is focused on the research and development
December S&P 500 futures (ESZ22) are trending up +0.26% this morning after three major US benchmark indices closed lower on Friday, notching their biggest weekly drop in more than a month, as hotter-than-anticipated...
Presented encouraging interim data for anti-DLL3 T cell engager HPN328 from ongoing dose escalation clinical trial at the 2022 ASCO Annual Meeting ...